Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cubist Pharmaceuticals Inc    

CUBIST PHARMACEUTICALS INC
Mes dernières consult.
Most popular
Report
 SummaryNewsAnalysisCompany 
Company
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development and commercialization of pharmaceutical products.The company was founded in 1992 and is headquartered in Lexington, MA. 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on CUBIST PHARMACEUTICALS INC
2015 CUBIST PHARMACEUTICALS : Announces Withdrawal of Listing of CVRs (CBSTZ) from NA..
2014 CUBIST PHARMACEUTICALS : Announces FDA Approval of New Antibiotic ZERBAXA™..
2014 CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Inves..
2014 CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Launches An Investigati..
2014 CUBIST PHARMACEUTICALS : CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong..
2014 CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inv..
2014 CUBIST PHARMACEUTICALS : CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces..
2014 CUBIST PHARMACEUTICALS : sales force seen as potential boon for Merck intestinal..
2014DJMerck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
2014 CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Inves..
More news
Sector news : Biopharmaceuticals
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
More sector news : Biopharmaceuticals
4-Traders Strategies on CUBIST PHARMACEUTICALS INC 
CUBIST PHARMACEUTICALS INC - 2013
Under a significant resistance
SELL
More Strategies
Sector and Competitors
1st jan.Capitalization (M$)
CUBIST PHARMACEUTICALS INC0
BIOGEN31.85%71 485
CSL LIMITED38.38%49 894
ALEXION PHARMACEUTICALS14.80%31 027
GRIFOLS SA30.11%17 818
BIOMARIN PHARMACEUTICAL6.98%15 380